Market Overview

Good Vaccine, Treatment News Will Cause A Rotation Out Of Tech, Brad Gerstner Says

Share:
Good Vaccine, Treatment News Will Cause A Rotation Out Of Tech, Brad Gerstner Says

On CNBC's "Fast Money Halftime Report," the investment committee and guests discussed stocks they're buying, problems delivering the vaccine and the vaccine's impact on the market.

  • Tiffany McGhee, Founder Of StocSavvy: Buying Peloton (NASDAQ: PTON), DocuSign (NASDAQ: DOCU), Salesforce (NYSE: CRM), ServiceNow (NYSE: NOW)
  • Stephen Weiss: The Bottleneck Is Delivering The Vaccine [At Low Temperatures], FedEx (NYSE: FDX) Says They're Adapting
  • Brad Gerstner, President Of Altimeter Capital, Says Dollars Are Going To Move Out Of Tech After Good Vaccine, Treatment News
 

Related Articles (CRM + DOCU)

View Comments and Join the Discussion!

Posted-In: Brad Gerstner CNBCTech Media Trading Ideas